Diffusion Pharmaceuticals... (DFFN)
NASDAQ: DFFN
· Real-Time Price · USD
4.40
0.41 (10.28%)
At close: Aug 16, 2023, 10:00 PM
Diffusion Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -4.89M | -12.24M | -9.62M | -2.32M | 2.15M | -2.11M | -4.09M | -4.08M | -2.8M | -4.19M | -4.53M | -3.47M | -12.2M | -3.78M | -4.64M |
Depreciation & Amortization | n/a | 50.58M | n/a | n/a | n/a | n/a | -50.58M | -208.58K | n/a | n/a | -13.55M | 26.11K | 19.1K | 23.75K | 24.45K |
Stock-Based Compensation | 361.17K | 1.22M | 1.01M | 578.58K | n/a | 60.66K | 121.37K | 189.91K | 181.88K | 278.13K | 278.13K | 254.31K | 164.39K | 297.28K | 181.28K |
Other Working Capital | n/a | 582.66K | -72.46K | n/a | n/a | 72.46K | -655.12K | 352.48K | 178.73K | 377.88K | -495.9K | -129.92K | 171.99K | 126.61K | -417.68K |
Other Non-Cash Items | n/a | -52.28M | -67.2K | n/a | -2.26M | -5.11K | 50.53M | 122.16K | -76.72K | -31.89K | -13.55K | 51.78K | 17.28M | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -443.89K | n/a | n/a |
Change in Working Capital | n/a | 1.54M | 588.49K | n/a | n/a | -588.49K | -946.53K | 499.16K | -65.64K | -62.93K | -467.76K | 116.75K | 848.27K | 129.53K | -738.18K |
Operating Cash Flow | -3.89M | -11.18M | -8.09M | n/a | 2.26M | -2.65M | -4.97M | -3.47M | -2.76M | -4.01M | -4.73M | -3.03M | -2.97M | -3.33M | -5.18M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -7.1M | -48.1M | -44.47M | n/a | n/a | n/a | n/a | -31.62M | -6.37M | -8.9M | -22.72M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 12.5M | 6.94M | 3.5M | n/a | n/a | 3M | 9.5M | 7M | 9.75M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 31.62M | n/a | 9M | n/a | 4K | n/a | n/a | n/a |
Investing Cash Flow | 5.4M | -41.16M | -40.97M | n/a | n/a | 3M | 9.5M | 7M | 3.38M | 100.59K | -22.72M | 4K | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | 6.99M | n/a | n/a | 5K | n/a | n/a | 5M | n/a | n/a | n/a | 33.3M |
Financial Cash Flow | n/a | 39.41M | 39.41M | n/a | 6.99M | n/a | n/a | 5K | n/a | n/a | 5K | n/a | n/a | n/a | 33.3M |
Net Cash Flow | 1.5M | -249.78K | -1.51M | n/a | 9.25M | 353.96K | 4.53M | 3.53M | 621.29K | -3.91M | -27.44M | -3.02M | -2.97M | -3.33M | 28.12M |
Free Cash Flow | -3.89M | -11.18M | -8.09M | n/a | 2.26M | -2.65M | -4.97M | -3.47M | -2.76M | -4.01M | -4.73M | -3.03M | -2.97M | -3.33M | -5.18M |